Jacob Nersting

2.0k total citations
49 papers, 1.0k citations indexed

About

Jacob Nersting is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Jacob Nersting has authored 49 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Public Health, Environmental and Occupational Health, 27 papers in Pediatrics, Perinatology and Child Health and 9 papers in Molecular Biology. Recurrent topics in Jacob Nersting's work include Acute Lymphoblastic Leukemia research (39 papers), Childhood Cancer Survivors' Quality of Life (25 papers) and Acute Myeloid Leukemia Research (6 papers). Jacob Nersting is often cited by papers focused on Acute Lymphoblastic Leukemia research (39 papers), Childhood Cancer Survivors' Quality of Life (25 papers) and Acute Myeloid Leukemia Research (6 papers). Jacob Nersting collaborates with scholars based in Denmark, Sweden and Norway. Jacob Nersting's co-authors include Kjeld Schmiegelow, Thomas Leth Frandsen, Stine Nygaard Nielsen, Kathrine Grell, Kim Vettenranta, Lisa Lyngsie Hjalgrim, Henrik Hasle, Susanne Rosthøj, Jón Kristinsson and Mats Heyman and has published in prestigious journals such as Blood, The Lancet Oncology and International Journal of Cancer.

In The Last Decade

Jacob Nersting

46 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacob Nersting Denmark 19 713 491 231 205 174 49 1.0k
Archie Bleyer United States 11 400 0.6× 338 0.7× 150 0.6× 183 0.9× 231 1.3× 22 883
Anders Glomstein Denmark 20 671 0.9× 472 1.0× 245 1.1× 644 3.1× 156 0.9× 42 1.4k
Yousif Matloub United States 18 621 0.9× 446 0.9× 160 0.7× 667 3.3× 179 1.0× 48 1.3k
Mei La United States 16 1.3k 1.9× 1.1k 2.1× 194 0.8× 542 2.6× 294 1.7× 22 1.6k
Lucie M. Turcotte United States 16 280 0.4× 386 0.8× 145 0.6× 92 0.4× 239 1.4× 79 911
Robert C. Trueworthy United States 15 365 0.5× 326 0.7× 111 0.5× 195 1.0× 91 0.5× 28 839
Anders Castor Sweden 18 806 1.1× 386 0.8× 455 2.0× 755 3.7× 309 1.8× 46 1.5k
Frank Alvaro Australia 15 212 0.3× 205 0.4× 102 0.4× 183 0.9× 173 1.0× 45 752
Roland Chu United States 11 168 0.2× 133 0.3× 322 1.4× 245 1.2× 202 1.2× 30 716
Wing H. Tong Netherlands 14 277 0.4× 236 0.5× 101 0.4× 92 0.4× 83 0.5× 28 642

Countries citing papers authored by Jacob Nersting

Since Specialization
Citations

This map shows the geographic impact of Jacob Nersting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Nersting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Nersting more than expected).

Fields of papers citing papers by Jacob Nersting

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob Nersting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Nersting. The network helps show where Jacob Nersting may publish in the future.

Co-authorship network of co-authors of Jacob Nersting

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob Nersting. A scholar is included among the top collaborators of Jacob Nersting based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob Nersting. Jacob Nersting is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pietri, Silvia De, Mathias Rathe, Thomas Leth Frandsen, et al.. (2023). Gastrointestinal barrier integrity and mucosal inflammation as risk factors of blood stream infections in children treated for acute lymphoblastic leukaemia. International Journal of Cancer. 153(9). 1635–1642. 6 indexed citations
2.
Yankilevich, Patricio, Luca Di Leo, Francesca M. Bosisio, et al.. (2022). Thiopurine 6TG treatment increases tumor immunogenicity and response to immune checkpoint blockade. OncoImmunology. 12(1). 2158610–2158610. 6 indexed citations
3.
Nersting, Jacob, Ruta Tuckuviene, Peder Skov Wehner, et al.. (2021). Socioeconomic position and maintenance therapy in children with acute lymphoblastic leukemia: A national cohort study. Pediatric Blood & Cancer. 69(7). e29508–e29508. 5 indexed citations
4.
Nielsen, Stine Nygaard, Kathrine Grell, Jacob Nersting, et al.. (2021). No association between relapse hazard and thiopurine methyltransferase geno- or phenotypes in non-high risk acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study. Cancer Chemotherapy and Pharmacology. 88(2). 271–279. 6 indexed citations
5.
Rank, Cecilie Utke, Kathrine Grell, Lisbeth Nørgaard Møller, et al.. (2021). Increments in DNA-thioguanine level during thiopurine-enhanced maintenance therapy of acute lymphoblastic leukemia. Haematologica. 106(11). 2824–2833. 15 indexed citations
6.
Rank, Cecilie Utke, Riitta Niinimäki, Jacob Nersting, et al.. (2021). Maintenance therapy and risk of osteonecrosis in children and young adults with acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study. Cancer Chemotherapy and Pharmacology. 88(5). 911–917. 8 indexed citations
7.
Larsen, Hanne Bækgaard, Susanne Rosthøj, Jacob Nersting, et al.. (2020). Interprofessional versus monoprofessional case-based learning in childhood cancer and the effect on healthcare professionals’ knowledge and attitudes: study protocol for a randomised trial. BMC Health Services Research. 20(1). 1124–1124. 4 indexed citations
8.
Hjalgrim, Lisa Lyngsie, Kathrine Grell, Kim Kristensen, et al.. (2020). Pharmacokinetics of tablet and liquid formulations of oral 6-mercaptopurine in children with acute lymphoblastic leukemia. Cancer Chemotherapy and Pharmacology. 86(1). 25–32. 11 indexed citations
9.
Nersting, Jacob, Stine Nygaard Nielsen, Kathrine Grell, et al.. (2018). Methotrexate polyglutamate levels and co-distributions in childhood acute lymphoblastic leukemia maintenance therapy. Cancer Chemotherapy and Pharmacology. 83(1). 53–60. 13 indexed citations
10.
Grosen, Anne, Jacob Nersting, Mona Bungum, et al.. (2018). Sperm DNA Integrity is Unaffected by Thiopurine Treatment in Men With Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 13(1). 3–11. 14 indexed citations
11.
Evensen, Nikki A., Julia Meyer, David J. Araten, et al.. (2018). MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia. Haematologica. 103(5). 830–839. 28 indexed citations
12.
Moriyama, Takaya, Rina Nishii, Ting-Nien Lin, et al.. (2017). The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemia. Pharmacogenetics and Genomics. 27(6). 236–239. 52 indexed citations
13.
Nielsen, Stine Nygaard, Kathrine Grell, Jacob Nersting, et al.. (2017). DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial. The Lancet Oncology. 18(4). 515–524. 74 indexed citations
14.
Schmiegelow, Kjeld, et al.. (2015). Mercaptopurine metabolite levels are predictors of bone marrow toxicity following high-dose methotrexate therapy of childhood acute lymphoblastic leukaemia. Cancer Chemotherapy and Pharmacology. 75(5). 1089–1093. 15 indexed citations
15.
Hjalgrim, Lisa Lyngsie, Jacob Nersting, Jörg Breitkreutz, et al.. (2015). Evaluation of a pediatric liquid formulation to improve 6-mercaptopurine therapy in children. European Journal of Pharmaceutical Sciences. 83. 1–7. 6 indexed citations
16.
Wesołowska, Aleksandra, Marlene Dalgaard, Laurent Gautier, et al.. (2011). Cost-effective multiplexing before capture allows screening of 25 000 clinically relevant SNPs in childhood acute lymphoblastic leukemia. Leukemia. 25(6). 1001–1006. 17 indexed citations
17.
Nersting, Jacob, et al.. (2011). Challenges in implementing individualized medicine illustrated by antimetabolite therapy of childhood acute lymphoblastic leukemia. Clinical Proteomics. 8(1). 8–8. 8 indexed citations
18.
Schmiegelow, Kjeld, et al.. (2011). Liquid chromatography–tandem mass spectrometry quantification of 6-thioguanine in DNA using endogenous guanine as internal standard. Journal of Chromatography B. 881-882. 115–118. 46 indexed citations
19.
Schmiegelow, Kjeld, Mette Klarskov Andersen, Mikael Behrendtz, et al.. (2009). Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study. Blood. 113(24). 6077–6084. 95 indexed citations
20.
Nersting, Jacob, Morten Svenson, Vagn Andersen, & Klaus Bendtzen. (2003). Maturation of human dendritic cells by monocyte-conditioned medium is dependent upon trace amounts of lipopolysaccharide inducing tumour necrosis factor α. Immunology Letters. 89(1). 59–65. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026